{"id":816286,"date":"2025-02-21T11:18:20","date_gmt":"2025-02-21T16:18:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/"},"modified":"2025-02-21T11:18:20","modified_gmt":"2025-02-21T16:18:20","slug":"lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/","title":{"rendered":"Lowey Dannenberg Notifies Novo Nordisk A\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Feb.  21, 2025  (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the \u201cClass Period\u201d).<\/p>\n<p>On January 24, 2025, a complaint was filed against the Company and certain of its officers, alleging that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that: (i) defendants created the false impression that they possessed reliable information pertaining to Novo\u2019s projected successful outcome of Novo\u2019s phase 3 CagriSema study on obesity, named \u201cREDEFINE-1,\u201d while avoiding discussions centered around dosage tolerability; (ii) Novo\u2019s repeated optimistic claims that CagriSema would achieve at least 25% weight loss in the REDEFINE-1 study fell short of reality; and (iii) the utilization of the \u201cflexible protocol\u201d limited the study\u2019s ability to effectively provide weight loss data on the dosage tested, suggesting either that tolerability was significantly worse than anticipated, resulting in patients titrating down their dosages to avoid complications, or that the patient selection process was rushed, leading to the onboarding of patients that did not desire to even achieve the 25% weight loss Novo sought to demonstrate.<\/p>\n<p>When investors learned the truth, Novo\u2019s common stock declined precipitously, injuring investors.<\/p>\n<p>If you suffered a loss of more than $200,000 in Novo\u2019s securities, and wish to participate, or learn more, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=x6hivR9o-WuSyX6xMls4vq69OcNfw2759245fweqPutaqzWD7QsOoGv2Qe9Gg4xyQ5UQYYeKpziKkkFZEpoP3-SLLq1l27mX0QOwoaOZwBk=\" rel=\"nofollow\" target=\"_blank\">click here<\/a>, or please contact our attorneys at (914) 733-7256 or via email to Andrea Farah (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=639W6BJYgst7zHkCrmkLljhmzNMK8SZL1HfByXJpOlNvNNJoFI8-xWAHL0uG-QRJzBFW-2TIGTPn5P_pMk0fJg==\" rel=\"nofollow\" target=\"_blank\">afarah@lowey.com<\/a>) or Vincent R. Cappucci Jr. (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ADmKOTSNbYjFbQnLodfxT7gOvBwbUAOp_yflrkRfa9KQwY3Fdajs_3O8Ob-0l_jqY03wgPcWs_WnaP-tuGgKQkJdT6tjSWzUjQ8ctqLXAvQ=\" rel=\"nofollow\" target=\"_blank\">vcappucci@lowey.com<\/a>).<\/p>\n<p>Any investor who wishes to serve as Lead Plaintiff must act before <strong>March 25, 2025<\/strong>.<\/p>\n<p>\n        <strong>About Lowey Dannenberg<\/strong><br \/>\n        <br \/>Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has recovered billions of dollars on behalf of its clients.<\/p>\n<p>\n        <strong>Contact<\/strong>:<br \/>Lowey Dannenberg P.C.<br \/>44 South Broadway, Suite 1100<br \/>White Plains, NY 10601<br \/>Tel: (914) 733-7234<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=639W6BJYgst7zHkCrmkLllTmnOSmceeEJd5_P6FBQ3qZzsIAnjwAkt-owx-tBZvOsi50lBVI3jHULr01WOk1zA==\" rel=\"nofollow\" target=\"_blank\">afarah@lowey.com<\/a>\u00a0<\/p>\n<p>\n        <strong>SOURCE<\/strong>: Lowey Dannenberg P.C.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjU3MiM2NzYyNjY4IzIxOTQ1MzQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDY5NzMzMmQtNDFjMC00MzhmLTljMTMtNDY4MWYxZmRiZDg2LTEyMDYwODc=\/tiny\/Lowey-Dannenberg-P-C-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the \u201cClass Period\u201d). On January 24, 2025, a complaint was filed against the Company and certain of its officers, alleging that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that: (i) defendants created the false impression that they possessed reliable information pertaining to Novo\u2019s projected successful outcome &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lowey Dannenberg Notifies Novo Nordisk A\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-816286","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lowey Dannenberg Notifies Novo Nordisk A\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lowey Dannenberg Notifies Novo Nordisk A\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the \u201cClass Period\u201d). On January 24, 2025, a complaint was filed against the Company and certain of its officers, alleging that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that: (i) defendants created the false impression that they possessed reliable information pertaining to Novo\u2019s projected successful outcome &hellip; Continue reading &quot;Lowey Dannenberg Notifies Novo Nordisk A\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-21T16:18:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjU3MiM2NzYyNjY4IzIxOTQ1MzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lowey Dannenberg Notifies Novo Nordisk A\\\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm\",\"datePublished\":\"2025-02-21T16:18:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\\\/\"},\"wordCount\":402,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjU3MiM2NzYyNjY4IzIxOTQ1MzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\\\/\",\"name\":\"Lowey Dannenberg Notifies Novo Nordisk A\\\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjU3MiM2NzYyNjY4IzIxOTQ1MzQ=\",\"datePublished\":\"2025-02-21T16:18:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjU3MiM2NzYyNjY4IzIxOTQ1MzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MjU3MiM2NzYyNjY4IzIxOTQ1MzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lowey Dannenberg Notifies Novo Nordisk A\\\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lowey Dannenberg Notifies Novo Nordisk A\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/","og_locale":"en_US","og_type":"article","og_title":"Lowey Dannenberg Notifies Novo Nordisk A\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm - Market Newsdesk","og_description":"NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the \u201cClass Period\u201d). On January 24, 2025, a complaint was filed against the Company and certain of its officers, alleging that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that: (i) defendants created the false impression that they possessed reliable information pertaining to Novo\u2019s projected successful outcome &hellip; Continue reading \"Lowey Dannenberg Notifies Novo Nordisk A\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-21T16:18:20+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjU3MiM2NzYyNjY4IzIxOTQ1MzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lowey Dannenberg Notifies Novo Nordisk A\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm","datePublished":"2025-02-21T16:18:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/"},"wordCount":402,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjU3MiM2NzYyNjY4IzIxOTQ1MzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/","name":"Lowey Dannenberg Notifies Novo Nordisk A\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjU3MiM2NzYyNjY4IzIxOTQ1MzQ=","datePublished":"2025-02-21T16:18:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjU3MiM2NzYyNjY4IzIxOTQ1MzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MjU3MiM2NzYyNjY4IzIxOTQ1MzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-novo-nordisk-a-s-novo-or-the-company-nyse-nvo-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-more-than-2-6\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lowey Dannenberg Notifies Novo Nordisk A\/S (\u201cNovo\u201d or the \u201cCompany\u201d) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=816286"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816286\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=816286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=816286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=816286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}